Continuous and batch reactors were used to assess the effect of the exposure of casein-coated silver nanoparticles (AgNPs) on Escherichia coli (E. coli). Additionally, E. coli membrane extracts, membrane permeability and Langmuir film balance assays were used to determine integrity and changes in lipid composition in response to AgNPs exposure. Results showed that batch conditions were not appropriate for the tests due to the production of exopolymeric substances (EPS) during the growth phase. After 5h of contact between AgNPs and the used growth media containing EPS, the nanoparticles increased in size from 86nm to 282nm reducing the stability and thus limiting cell-nanoparticle interactions. AgNPs reduced E. coli growth by 20% at 1mg/L, in terms of Optical Density 670 (OD670), while no effect was detected at 15mg/L. At 50mg/L of AgNPs was not possible to perform the test due to aggregation and sedimentation of the nanoparticles. Membrane extract assays showed that at 1mg/L AgNPs had a greater change in area (-4.4cm(2)) on bacteria compared to 15mg/L (-4.0cm(2)). This area increment suggested that membrane disruption caused by AgNPs had a stabilizing/rigidifying effect where the cells responded by shifting their lipid composition to more unsaturated lipids to counteract membrane rigidification. In chemostats, the constant inflow of fresh media and aeration resulted in less AgNPs aggregation, thus increased the AgNPs-bacteria interactions, in comparison to batch conditions. AgNPs at 1mg/L, 15mg/L, and 50mg/L inhibited the growth (OD670 reduction) by 0%, 11% and 16.3%, respectively. Membrane extracts exposed to 1mg/L, 15mg/L, and 50mg/L of AgNPs required greater changes in area by -0.5cm(2), 2.7cm(2) and 3.6cm(2), respectively, indicating that the bacterial membranes were disrupted and bacteria responded by synthesizing lipids that stabilize or strengthen membranes. This study showed that the chemostat is more appropriate for the testing of nanotoxicological effects when testing bacteria at growing conditions.
We have examined the interactions between polymer-coated anionic (Ag-COOH) and cationic (Ag-NH) silver nanoparticles, and net-anionic lipid monolayers using dynamic surface pressure measurements. Monolayers composed of saturated or monounsaturated mixtures of anionic phosphatidylglycerol (PG) and zwitterionic phosphatidylcholine (PC) lipids (3:1 molar ratio) were used to determine how lipid packing and monolayer phase state influence the extent of nanoparticle binding and the monolayer response. Anionic Ag-COOH inserted into saturated dipalmitoyl-PC/PG (DPPC/DPPG) and dioleoyl-PC/PG (DOPC/DOPG) monolayers at a low initial surface pressure (10 mN m) and caused lipid condensation at high initial surface pressures (20 and 30 mN m). Hydrophobic interactions were responsible for insertion, while electrostatic and charge-dipole interactions with PCs were responsible for condensation. In contrast, cationic Ag-NH inserted only into saturated DPPC/DPPG monolayers and otherwise led to lipid condensation. For Ag-NH, adsorption was driven primarily by electrostatic interactions with PGs. Analysis of the subphase Ag and phosphorus concentrations confirmed that Ag-NH had a higher degree binding compared to Ag-COOH, and that the monolayer response was not due to lipid extraction.
Aerobic oxidation of alcohols to carboxylic acids and ketones in water using palladium species supported on an ordered mesoporous polypyrrole/carbon nanocomposite.
We have investigated the surface activity of poly(ethylene glycol) (PEG)-coated silver nanoparticles (Ag-PEG) in the presence or absence of lipid monolayers comprised of monounsaturated dioleoylphosphocholine and dioleoylphosphoglycerol (DOPC/DOPG; 1:1 mol ratio). Dynamic measurements of surface pressure demonstrated that Ag-PEG were surface-active at the air/water interface. Surface excess concentrations suggested that at high Ag-PEG subphase concentrations, Ag-PEG assembled as densely packed monolayers in the presence and absence of a lipid monolayer. The presence of a lipid monolayer led to only a slight decrease in the excess surface concentration of Ag-PEG. Surface pressure-area isotherms showed that in the absence of lipids Ag-PEG increased the surface pressure up to 45 mN m upon compression before the Ag-PEG surface layer collapsed. Our results suggest that surface activity of Ag-PEG was due to hydrophobic interactions imparted by a combination of the amphiphilic polymer coating and the hydrophobic dodecanethiol ligands bound to the Ag-PEG surface. With lipid present, Ag-PEG + lipid surface pressure-area (π-A) isotherms reflected Ag-PEG incorporation within the lipid monolayers. At high Ag-PEG concentrations, the π-A isotherms of the Ag-PEG + lipid films closely resembled that of Ag-PEG alone with a minimal contribution from the lipids present. Analysis of the subphase silver (Ag) and phosphorus (P) concentrations revealed that most of the adsorbed material remained at the air/lipid/water interface and was not forced into the aqueous subphase upon compression, confirming the presence of a composite Ag-PEG + lipid film. While interactions between "water-soluble" nanoparticles and lipids are often considered to be dominated by electrostatic interactions, these results provide further evidence that the amphiphilic character of a nanoparticle coating can also play a significant role.
A green one-pot four-component strategy has been developed for the synthesis of [1,2,4]triazolo[1,5-a]pyrimidine-6-carboxamide derivatives using an amine, 2,2,6-trimethyl-4H-1,3-dioxin-4-one, an aldehyde, and 3-amino-1,2,4-triazole in the presence of a catalytic amount of p-toluenesulfonic acid in water within 4-6 h.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.